Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 1,801,809	$ 1,543,418
Accounts receivable, net	303,760	54,991
Inventory, net	209,755	254,491
Prepaid insurance and services	150,322	101,135
Prepaid clinical expenses	3,045,870	2,204,520
Total current assets	5,511,516	4,158,555
FURNITURE AND EQUIPMENT, NET	40,731	55,188
RIGHT-OF-USE LEASE ASSET, NET	44,819	1,470
TOTAL ASSETS	5,597,066	4,215,213
Current portion of lease liability	17,973	0
Accounts payable and accrued expenses	6,604,504	3,480,669
Total current liabilities	6,622,477	3,480,669
LONG-TERM LIABILITIES
Lease liability, net of current portion	27,259	0
Total long-term liabilities	27,259	0
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock, par value $.0001 per share, 50,000,000 and 20,000,000 shares authorized, 19,365,089 and 8,481,848 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	1,937	849
Preferred stock, par value $.0001 per share, 5,000,000 shares authorized, 0 outstanding	0	0
Additional paid-in capital	77,159,665	64,533,074
Accumulated deficit	(78,214,272)	(63,799,379)
Total stockholders' equity (deficit)	(1,052,670)	734,544
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 5,597,066	$ 4,215,213